MeSH tree: G07.345.249.314
People taking popular GLP-1 medications such as Ozempic, Wegovy and Zepbound may face stigma from those closest to them, according to a new study by a Florida State University professor.
11 hours ago
0
3
Semaglutide is known to reduce the risk of serious heart disease. However, a new study published in the European Heart Journal suggests that this effect cannot be entirely explained by patients losing weight on the drug.
Sep 23, 2026
0
9
Every time a person sees a doctor, the visit produces two kinds of records. There are the tidy checkbox fields: the billing codes, the lab values, the prescription entries. And there is the note the clinician actually writes, ...
Sep 18, 2026
0
27
Scrolling through social media can mean encountering a supplement promising better health, a drink offering quick weight loss or a food promoted as a "superfood." For people looking for advice on what to eat, distinguishing ...
Sep 18, 2026
0
4
Eating four to six servings of whole grains each day reduces several major risk factors for cardiovascular disease, according to a new study published in the European Heart Journal. The study is a systematic review and meta-analysis, ...
Sep 15, 2026
0
51
A Johns Hopkins Medicine study reports evidence that time-restricted eating (TRE)—a form of intermittent fasting that involves eating only during a consistent daily 8–10-hour window—can cause modest weight loss in adults ...
Sep 14, 2026
0
105
A newly published narrative review in the journal Nutrients brings together findings from three large European research consortia—SWEET, SWITCH and Sweet Tooth—to address longstanding questions about whether non-nutritive ...
Sep 8, 2026
0
52
U.S. Defense Secretary Pete Hegseth has been criticized after sharing a photograph of two people in uniform from a Canadian youth cadet program with the caption "this is real." The image showed a teenage cadet receiving a ...
Sep 7, 2026
0
5
We've all been there. You spend an hour at the gym, and before you even reach the locker room, you start thinking about your favorite takeout meal—after all, you've earned it!
Sep 4, 2026
0
15
An updated systematic review evaluating the efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and coagonists among adults with overweight or obesity without diabetes found that, among currently ...
Sep 1, 2026
0
19
